Redhill Biopharma Ltd (RDHL)
0.4513
0.00 (0.00%)
USD |
NASDAQ |
May 02, 16:00
0.4513
0.00 (0.00%)
After-Hours: 17:24
Redhill Biopharma Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | -2.380 |
September 30, 2022 | -2.474 |
June 30, 2022 | -7.161 |
March 31, 2022 | -16.48 |
December 31, 2021 | 9.422 |
September 30, 2021 | 7.231 |
June 30, 2021 | 2.811 |
March 31, 2021 | 1.556 |
December 31, 2020 | 5.870 |
September 30, 2020 | 2.792 |
June 30, 2020 | 2.290 |
March 31, 2020 | 1.791 |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | 0.00 |
September 30, 2018 | 0.00 |
June 30, 2018 | 0.00 |
March 31, 2018 | 0.00 |
December 31, 2017 | 0.00 |
September 30, 2017 | 0.00 |
Date | Value |
---|---|
June 30, 2017 | 0.00 |
March 31, 2017 | 0.00 |
December 31, 2016 | 0.00 |
September 30, 2016 | 0.00 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
September 30, 2015 | 0.00 |
June 30, 2015 | 0.00 |
March 31, 2015 | 0.00 |
December 31, 2014 | 0.00 |
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | |
March 31, 2012 | |
December 31, 2011 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-16.48
Minimum
Mar 2022
9.422
Maximum
Dec 2021
0.31
Average
--
Median
Jun 2019
Debt to Equity Ratio Benchmarks
Compugen Ltd | 0.00 |
Pluri Inc | 5.547 |
BioLine Rx Ltd | 0.7391 |
Can Fite Biofarma Ltd | 0.00 |
BiomX Inc | -- |
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 35.04M |
Total Liabilities (Quarterly) | 31.57M |
Shareholders Equity (Quarterly) | 3.471M |